Malignant Pleural Neoplasm — Trials

Malignant Pleural Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

124 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 26
Recruiting: 12
Ph III recruiting: 0
Growth YoY: —
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 30.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (18)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05582031	Regorafenib With Tislelizumab in Patients With Selected Mismatch Repair-Proficient/Microsatellite Stable Cancers(REFIT-MSS)	withdrawn	Phase 2	0	Translational Research in OncologyOTHER	0	Jun 7, 2023	clinicaltrials
NCT03786419	A Study of Atezolizumab in Unresectable or Advaced Malignant Pleural Mesothelioma	withdrawn	Phase 2	0	Health Pharma Professional ResearchOTHER	1	May 13, 2021